Viewing Study NCT05690035


Ignite Creation Date: 2025-12-24 @ 10:20 PM
Ignite Modification Date: 2025-12-25 @ 7:53 PM
Study NCT ID: NCT05690035
Status: WITHDRAWN
Last Update Posted: 2024-07-09
First Post: 2023-01-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Tislelizumab Combined With Fruquintinib for Metastatic pMMR/MSS Colorectal Cancer
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module